Brandywine Oak Private Wealth LLC Catalent, Inc. Transaction History

Brandywine Oak Private Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$87.2 - $114.05 $83,886 - $109,716	962 Added 36.75%	3,580 $384,000
Q1 2022 May 02, 2022	BUY	$94.19 - $124.49 $52,087 - $68,842	553 Added 26.78%	2,618 $290,000
Q4 2021 Feb 07, 2022	SELL	$119.57 - $139.07 $23,077 - $26,840	-193 Reduced 8.55%	2,065 $275,000
Q3 2021 Oct 18, 2021	SELL	$109.17 - $142.35 $2,620 - $3,416	-24 Reduced 1.05%	2,258 $300,000
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $5,619 - $6,478	56 Added 2.52%	2,282 $246,000
Q1 2021 May 06, 2021	SELL	$101.51 - $125.27 $25,377 - $31,317	-250 Reduced 10.1%	2,226 $234,000
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $15,200 - $18,648	-177 Reduced 6.67%	2,476 $257,000
Q3 2020 Oct 16, 2020	SELL	$72.74 - $92.5 $33,896 - $43,105	-466 Reduced 14.94%	2,653 $227,000
Q2 2020 Aug 06, 2020	BUY	$48.02 - $79.04 $149,774 - $246,525	3,119 New	3,119 $228,000
Q1 2019 May 09, 2019	SELL	$29.84 - $43.92 $94,324 - $138,831	-3,161 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $94,671 - $146,480	3,161 New	3,161 $100,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.